Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
42.6 CHF | +0.35% | +0.95% | -0.35% |
Apr. 27 | Tranche Update on BB Biotech AG?s Equity Buyback Plan announced on April 12, 2022. | CI |
Apr. 26 | Switzerland's BB Biotech Swings to Q1 Profit; Operating Income Jumps | MT |
Sales 2024 * | 190M 209M | Sales 2025 * | 101M 111M | Capitalization | 2.33B 2.56B |
---|---|---|---|---|---|
Net income 2024 * | 152M 167M | Net income 2025 * | 72M 79.23M | EV / Sales 2024 * | 13.8 x |
Net Debt 2024 * | 291M 320M | Net Debt 2025 * | 324M 357M | EV / Sales 2025 * | 26.4 x |
P/E ratio 2024 * |
15.3
x | P/E ratio 2025 * |
14.2
x | Employees | 10 |
Yield 2024 * |
5.54% | Yield 2025 * |
5.65% | Free-Float | 97.24% |
1 day | +0.24% | ||
1 week | +0.71% | ||
Current month | +2.78% | ||
1 month | -1.28% | ||
3 months | -11.09% | ||
6 months | +10.10% | ||
Current year | -0.58% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel Koller
CIO | Chief Investment Officer | 54 | 03-12-31 |
- | - | ||
- | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Clive Meanwell
BRD | Director/Board Member | 67 | 03-12-31 |
Director/Board Member | 63 | 19-12-31 | |
Chairman | 63 | 19-03-20 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 42.6 | +0.35% | 39 204 |
24-05-07 | 42.45 | +0.71% | 69,813 |
24-05-06 | 42.15 | -0.12% | 67,076 |
24-05-03 | 42.2 | 0.00% | 63,009 |
24-05-02 | 42.2 | +2.06% | 73,553 |
Delayed Quote Swiss Exchange, May 08, 2024 at 04:29 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-0.58% | 2.57B | |
+21.74% | 46.4B | |
-0.97% | 41.75B | |
+49.45% | 41.37B | |
-3.52% | 29.71B | |
+11.12% | 26.01B | |
-19.37% | 19.52B | |
+31.18% | 12.43B | |
-0.04% | 12.13B | |
+0.39% | 12.18B |
- Stock Market
- Equities
- BION Stock